Uttar Pradesh News Desk

Graves Disease Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited

 Breaking News
  • No posts were found

Graves Disease Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited

January 16
19:52 2023
Graves Disease Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited
The Graves Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves Disease pipeline products will significantly revolutionize the Graves Disease market dynamics.

DelveInsight’s “Graves Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Graves Disease, historical and forecasted epidemiology as well as the Graves Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Graves Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Graves Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Graves Disease Market Insights

 

Graves Disease Overview

Graves’ Disease is a common form of hyperthyroidism. In this autoimmune disease, the immune system creates antibodies known as thyroid-stimulating immunoglobulins. They then attach to healthy thyroid cells thus, causing one’s thyroid to create too much thyroid hormone.

 

Some of the key facts of the Graves Disease Market Report: 

  • The Graves Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the Graves’ disease and thyroid foundation, Graves’ disease, also known as toxic diffuse goiter, is the most common cause of hyperthyroidism – a disorder that occurs when the thyroid gland makes more thyroid hormone than the body needs
  • According to National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), the disease affects about 1 in 200 people in the United States and is the most common cause of hyperthyroidism
  • The National Institute of Diabetes and Digestive and Kidney Diseases (n.d.), estimates that 30 percent of people who develop Graves’ disease will get a mild case of Graves’ ophthalmopathy. Up to 5 percent will get severe Graves’ ophthalmopathy
  • Key Graves Disease Companies: Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited, and others
  • Key Graves Disease Therapies: Secukinumab, Cyclopeptides, ATX-GD-59, K1-70, and others
  • The Graves Disease epidemiology based on gender analyzed that the Graves’ Disease is 7-8 times more common in women than men

 

Get a Free sample for the Graves Disease Market Report – 

https://www.delveinsight.com/sample-request/graves-disease-market

 

Key benefits of the Graves Disease Market report:

  1. Graves Disease market report covers a descriptive overview and comprehensive insight of the Graves Disease Epidemiology and Graves Disease market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Graves Disease market report provides insights on the current and emerging therapies.
  3. Graves Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Graves Disease market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Graves Disease market.

 

Download the report to understand which factors are driving Graves Disease epidemiology trends @ Graves Disease Epidemiological Insights 

 

Graves Disease Market  

The dynamics of the Graves Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“The DAVIAD project successfully resulted in the manufacture GMP grade ATX-GD-59 and completion of pharmacodynamic and toxicology studies in order to progress the therapeutic vaccine into a Phase I/IIa clinical trial. In the clinical trial, the vaccine was proven to be safe and well tolerated.”

 

Graves Disease Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Graves Disease Epidemiology Segmentation:

The Graves Disease market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Graves Disease
  • Prevalent Cases of Graves Disease by severity
  • Gender-specific Prevalence of Graves Disease
  • Diagnosed Cases of Episodic and Chronic Graves Disease

 

Graves Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Graves Disease market or expected to get launched during the study period. The analysis covers Graves Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Graves Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Graves Disease market share @ Graves Disease market forecast 

 

Graves Disease Therapies and Key Companies

  • Secukinumab: Novartis
  • Cyclopeptides: AdvanceCor
  • ATX-GD-59: Apitope/ Worg Pharmaceuticals
  • K1-70: AV7 Limited

 

Graves Disease Market Strengths

  • Important progress has been made regarding understanding disease pathology, diagnosis, and treatment effects in Fabry disease
  • Newborn screening for Fabry disease has been implemented in several countries, enabling the early detection of individuals with Fabry mutations
  • Many therapies are under investigation in various phases of clinical trials. These include pegylated forms of α-GAL, gene therapy, and substrate reduction therapy

 

Scope of the Graves Disease Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Graves Disease Companies: Novartis, AdvanceCor, Apitope, Worg Pharmaceuticals, AV7 Limited, and others
  • Key Graves Disease Therapies: Secukinumab, Cyclopeptides, ATX-GD-59, K1-70, and others
  • Graves Disease Therapeutic Assessment: Graves Disease current marketed and Graves Disease emerging therapies
  • Graves Disease Market Dynamics: Graves Disease market drivers and Graves Disease market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Graves Disease Unmet Needs, KOL’s views, Analyst’s views, Graves Disease Market Access and Reimbursement 

 

Graves Disease Market Unmet Needs

  • Challenges in diagnosis
  • Development of novel therapies
  • Limitations in gene therapy
  • Poor disease understanding
  • Clinical biomarkers

 

Table of Contents 

1. Graves Disease Market Report Introduction

2. Executive Summary for Graves Disease

3. SWOT analysis of Graves Disease

4. Graves Disease Patient Share (%) Overview at a Glance

5. Graves Disease Market Overview at a Glance

6. Graves Disease Disease Background and Overview

7. Graves Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Graves Disease 

9. Graves Disease Current Treatment and Medical Practices

10. Graves Disease Unmet Needs

11. Graves Disease Emerging Therapies

12. Graves Disease Market Outlook

13. Country-Wise Graves Disease Market Analysis (2019–2032)

14. Graves Disease Market Access and Reimbursement of Therapies

15. Graves Disease Market Drivers

16. Graves Disease Market Barriers

17.  Graves Disease Appendix

18. Graves Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Graves Disease treatment, visit @ Graves Disease Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles